Alloksys reports interim results of its clinical phase IIb trial with Alkaline Phosphatase therapy RESCAP® in critical care patients



Examination of sub-population data, with patient stratification, demonstrated promising results, despite interim analysis on the entire patient cohort not revealing significant differences between the RESCAP® and placebo groups for all endpoints Specifically, among patients with a normal…

Leave a Reply